Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheridan

Showing results (61-70 of 7,538) with videos related to

Pageof 754
Sort By:
Nature Biotechnology|December 10, 2015
Anti-CD20 antibody wows in multiple sclerosisCormac Sheridan
Mississippi RN|March 1, 1989
Survey reveals nursing shortage in state: is there a nursing shortage in Mississippi?M Sheridan
Nature Biotechnology|August 9, 2017
First new drug approval for AML in 15 yearsCormac Sheridan
Nature Biotechnology|September 13, 2017
CRISPR patent estate splintersCormac Sheridan
Nursing Times|May 6, 1989
Mental health--baffle locks: in whose best interest?G Sheridan
The Permanente Journal|June 29, 2016
You Are Not Alone: Ten Strategies for Surviving a Malpractice LawsuitAudrey Sheridan
Nature Biotechnology|September 25, 2020
Convalescent plasma falls flat in first randomized trialCormac Sheridan
Nature Biotechnology|July 16, 2021
CRISPR therapies march into clinic, but genotoxicity concerns lingerCormac Sheridan
Nature Biotechnology|June 14, 2023
Why gene therapies must go virus-freeCormac Sheridan
Nature Biotechnology|June 15, 2022
Topical herpesvirus gene therapy enters final lapCormac Sheridan
Pageof 754

Showing results (61-70 of 7,538) with videos related to

Sort By:
Pageof 754
Nature Biotechnology|December 10, 2015
Anti-CD20 antibody wows in multiple sclerosisCormac Sheridan
Mississippi RN|March 1, 1989
Survey reveals nursing shortage in state: is there a nursing shortage in Mississippi?M Sheridan
Nature Biotechnology|August 9, 2017
First new drug approval for AML in 15 yearsCormac Sheridan
Nature Biotechnology|September 13, 2017
CRISPR patent estate splintersCormac Sheridan
Nursing Times|May 6, 1989
Mental health--baffle locks: in whose best interest?G Sheridan
The Permanente Journal|June 29, 2016
You Are Not Alone: Ten Strategies for Surviving a Malpractice LawsuitAudrey Sheridan
Nature Biotechnology|September 25, 2020
Convalescent plasma falls flat in first randomized trialCormac Sheridan
Nature Biotechnology|July 16, 2021
CRISPR therapies march into clinic, but genotoxicity concerns lingerCormac Sheridan
Nature Biotechnology|June 14, 2023
Why gene therapies must go virus-freeCormac Sheridan
Nature Biotechnology|June 15, 2022
Topical herpesvirus gene therapy enters final lapCormac Sheridan
Pageof 754